BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18509604)

  • 1. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
    Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
    Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
    de Graaf W; Häusler S; Heger M; van Ginhoven TM; van Cappellen G; Bennink RJ; Kullak-Ublick GA; Hesselmann R; van Gulik TM; Stieger B
    J Hepatol; 2011 Apr; 54(4):738-45. PubMed ID: 21163547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
    Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
    Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
    Swift B; Yue W; Brouwer KL
    Pharm Res; 2010 Sep; 27(9):1987-98. PubMed ID: 20652625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker.
    Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T
    Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
    Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
    J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist).
    Sandoval P; Chuang BC; Fallon JK; Smith PC; Chowdhury SK; Griffin RJ; Xia CQ; Iwasaki S; Chothe PP
    AAPS J; 2022 Sep; 24(6):99. PubMed ID: 36123502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
    PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
    Keppler D
    Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
    Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in bilirubin metabolism and their clinical implications.
    Sticova E; Jirsa M
    World J Gastroenterol; 2013 Oct; 19(38):6398-407. PubMed ID: 24151358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
    Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
    J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin.
    Bhargava KK; Joseph B; Ananthanarayanan M; Balasubramaniyan N; Tronco GG; Palestro CJ; Gupta S
    J Nucl Med; 2009 Jul; 50(7):1140-6. PubMed ID: 19525466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.
    Visentin M; Stieger B; Merz M; Kullak-Ublick GA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia.
    Chang JH; Plise E; Cheong J; Ho Q; Lin M
    Mol Pharm; 2013 Aug; 10(8):3067-75. PubMed ID: 23750830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
    Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
    Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.